ATE423135T1 - Heterodimere peptide mit ngf aktivität und deren verwendung zur behandlung von neurodegenerativen krankheiten - Google Patents

Heterodimere peptide mit ngf aktivität und deren verwendung zur behandlung von neurodegenerativen krankheiten

Info

Publication number
ATE423135T1
ATE423135T1 AT05012643T AT05012643T ATE423135T1 AT E423135 T1 ATE423135 T1 AT E423135T1 AT 05012643 T AT05012643 T AT 05012643T AT 05012643 T AT05012643 T AT 05012643T AT E423135 T1 ATE423135 T1 AT E423135T1
Authority
AT
Austria
Prior art keywords
treatment
neurodegenerative diseases
loop
ngf
ngf activity
Prior art date
Application number
AT05012643T
Other languages
English (en)
Inventor
Luigi Vitagliano
Laura Zaccaro
Giancarlo Morelli
Enzo Martegani
Original Assignee
Primm Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Primm Srl filed Critical Primm Srl
Application granted granted Critical
Publication of ATE423135T1 publication Critical patent/ATE423135T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/48—Nerve growth factor [NGF]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT05012643T 2005-06-13 2005-06-13 Heterodimere peptide mit ngf aktivität und deren verwendung zur behandlung von neurodegenerativen krankheiten ATE423135T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05012643A EP1734052B1 (de) 2005-06-13 2005-06-13 Heterodimere Peptide mit NGF Aktivität und deren Verwendung zur Behandlung von neurodegenerativen Krankheiten

Publications (1)

Publication Number Publication Date
ATE423135T1 true ATE423135T1 (de) 2009-03-15

Family

ID=35276556

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05012643T ATE423135T1 (de) 2005-06-13 2005-06-13 Heterodimere peptide mit ngf aktivität und deren verwendung zur behandlung von neurodegenerativen krankheiten

Country Status (5)

Country Link
US (1) US8461110B2 (de)
EP (2) EP1734052B1 (de)
AT (1) ATE423135T1 (de)
DE (1) DE602005012812D1 (de)
WO (1) WO2006133853A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2630668C (en) * 2005-11-22 2016-07-12 Mcgill University Intraocular pressure-regulated early genes and uses thereof
EP1921087A1 (de) * 2006-11-10 2008-05-14 Primm S.R.L. Verfahren zur Herstellung von cyclischen Peptiden
US20080132451A1 (en) * 2006-12-01 2008-06-05 Alcon Manufacturing Ltd. Modulation of polysialylated neural adhesion molecules (psa-ncam) as a regulator of ocular disease
JP5576659B2 (ja) * 2006-12-05 2014-08-20 ザ ロイヤル インスティテューション フォー ジ アドバンスメント オブ ラーニング／ マギル ユニバーシティ Ｔｒｋレセプター調節因子の使用方法
ITRM20070119A1 (it) * 2007-03-08 2008-09-09 Inbios S R L Udo del ngf per la preparazione di mendicamenti per la cura della gliosi reattiva
MX2010006610A (es) * 2007-12-20 2010-09-30 Cytos Biotechnology Ag Conjugados de factor de crecimiento de nervios y usos de los mismos.
ES2521515T3 (es) 2008-04-04 2014-11-12 Mimetogen Pharmaceuticals Inc. Compuestos cíclicos peptidomiméticos con giro beta para tratar el ojo seco
CA2752891C (en) 2009-02-27 2018-08-21 Mimetogen Pharmaceuticals Inc. Peptidomimetic cyclic compounds for treating retinitis pigmentosa
US9078878B2 (en) 2010-12-01 2015-07-14 Alderbio Holdings Llc Anti-NGF antibodies that selectively inhibit the association of NGF with TrkA, without affecting the association of NGF with p75
US9884909B2 (en) 2010-12-01 2018-02-06 Alderbio Holdings Llc Anti-NGF compositions and use thereof
US11214610B2 (en) 2010-12-01 2022-01-04 H. Lundbeck A/S High-purity production of multi-subunit proteins such as antibodies in transformed microbes such as Pichia pastoris
US9067988B2 (en) 2010-12-01 2015-06-30 Alderbio Holdings Llc Methods of preventing or treating pain using anti-NGF antibodies
US9539324B2 (en) 2010-12-01 2017-01-10 Alderbio Holdings, Llc Methods of preventing inflammation and treating pain using anti-NGF compositions
EP2646468B1 (de) 2010-12-01 2018-07-25 AlderBio Holdings LLC Anti-ngf-zusammensetzungen und ihre verwendung
US9115179B2 (en) * 2012-06-22 2015-08-25 Mimetogen Pharmaceuticals Inc. Synthesis of beta-turn peptidomimetic cyclic compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9402331D0 (en) * 1994-02-07 1994-03-30 Univ Mcgill Nerve growth factor structural analogs and their uses
US5958875A (en) * 1996-03-29 1999-09-28 The Regents Of The University Of California Synthetic peptides derivatives with nerve growth factor-like neurotrophic activity

Also Published As

Publication number Publication date
US20090318335A1 (en) 2009-12-24
US8461110B2 (en) 2013-06-11
EP1891099A1 (de) 2008-02-27
WO2006133853A1 (en) 2006-12-21
EP1734052B1 (de) 2009-02-18
EP1734052A1 (de) 2006-12-20
DE602005012812D1 (de) 2009-04-02

Similar Documents

Publication Publication Date Title
ATE423135T1 (de) Heterodimere peptide mit ngf aktivität und deren verwendung zur behandlung von neurodegenerativen krankheiten
ATE517119T1 (de) Einzelketteninsulin
AR021448A1 (es) Metodo para producir un polipeptido quimerico
DK1877435T4 (da) Glucagon-lignende-peptid-2 (glp-2)-analoger
CY1113850T1 (el) Νεα παραγωγα ινσουλινης
ATE495739T1 (de) Pharmazeutische zusammensetzungen und verfahren zur verwendung von levodopa und carbidopa
DE602005010246D1 (de) Oligopeptide zur verringerung erhöhter blutharnstoffkonzentration
WO2007047829A3 (en) Novel heterodimeric proteins and uses thereof
ATE540980T1 (de) Proteinkomplex mit immunglobulinfragment und verfahren zu dessen herstellung
ATE525082T1 (de) Compstatin-analoga mit verbesserter wirkung
SI1873166T1 (sl) IZBOLJĹ ANI sgp 130Fc DIMERJI
ATE383865T1 (de) Apolipoprotein a-i agonisten und deren verwendung zur behandlung dyslipidämischer erkrankungen
TR199802252T2 (xx) N�ral ve renal geli�menin uyar�lmas� i�in ret ligand� (RetL)
EP2631242A3 (de) Verfahren zur Konzentration eines Polypeptids
ATE346095T1 (de) Glycoprotein vi - fc fusions protein zur behandlung von gefässerkrankungen
CY1114619T1 (el) Συνθετικα αναλογα πεπτιδιων νευρικης αναγεννησης
IS6072A (is) Æðasamloðunar sameindir og mótun á starfsemi þeirra
NZ562436A (en) Toll-like receptor 14 (TLR14) and use thereof
CY1106070T1 (el) Πολυμορφισμοι στο γονιδιο c μεταφορας οργανικου ανιοντος ανθρωπου (oatp-c) - (organic anion transporter c gene)
ATE452903T1 (de) Modifizierte peptide und deren verwendung zur behandlung von autoimmunkrankheiten
DE602005014990D1 (de) Morbus-crohn-antikörperepitoppeptid und reagens zum testen auf morbus crohn
ATE538806T1 (de) Peptide mit spezifischem sitz in herzgefässen und verwandte konjugate und verfahren
NO20082864L (no) Nytt polypeptid med esteraseaktivitet og rekombinant esterase samt anvendelse derav
EP1467207A4 (de) Screening-verfahren
DE60329931D1 (de) Fprl1-liganden und deren verwendung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties